Literature DB >> 23001802

Acute interstitial pneumonia (AIP): relationship to Hamman-Rich syndrome, diffuse alveolar damage (DAD), and acute respiratory distress syndrome (ARDS).

Sanjay Mukhopadhyay1, Joseph G Parambil.   

Abstract

Acute interstitial pneumonia (AIP) is a term used for an idiopathic form of acute lung injury characterized clinically by acute respiratory failure with bilateral lung infiltrates and histologically by diffuse alveolar damage (DAD), a combination of findings previously known as the Hamman-Rich syndrome. This review aims to clarify the diagnostic criteria of AIP, its relationship with DAD and acute respiratory distress syndrome (ARDS), key etiologies that need to be excluded before making the diagnosis, and the salient clinical features. Cases that meet clinical and pathologic criteria for AIP overlap substantially with those that fulfill clinical criteria for ARDS. The main differences between AIP and ARDS are that AIP requires a histologic diagnosis of DAD and exclusion of known etiologies. AIP should also be distinguished from "acute exacerbation of IPF," a condition in which acute lung injury (usually DAD) supervenes on underlying usual interstitial pneumonia (UIP)/idiopathic pulmonary fibrosis (IPF). Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2012        PMID: 23001802     DOI: 10.1055/s-0032-1325158

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN: 1069-3424            Impact factor:   3.119


  19 in total

1.  [Acute on chronic respiratory failure in interstitial pneumonias].

Authors:  M Westhoff
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-08-16       Impact factor: 0.840

2.  Up-regulation of THY1 attenuates interstitial pulmonary fibrosis and promotes lung fibroblast apoptosis during acute interstitial pneumonia by blockade of the WNT signaling pathway.

Authors:  Lin Chen; Rong-Zhen Tang; Jia Ruan; Xiao-Bo Zhu; Yang Yang
Journal:  Cell Cycle       Date:  2019-03-04       Impact factor: 4.534

3.  Acute respiratory distress syndrome in patients with and without diffuse alveolar damage: an autopsy study.

Authors:  José A Lorente; Pablo Cardinal-Fernández; Diego Muñoz; Fernando Frutos-Vivar; Arnaud W Thille; Carlos Jaramillo; Aida Ballén-Barragán; José M Rodríguez; Oscar Peñuelas; Guillermo Ortiz; José Blanco; Bruno Valle Pinheiro; Nicolás Nin; María del Carmen Marin; Andrés Esteban; Taylor B Thompson
Journal:  Intensive Care Med       Date:  2015-09-18       Impact factor: 17.440

4.  Retrospective immunohistological study of autopsied lungs in patients with acute exacerbation of interstitial pneumonia managed with extracorporeal membrane oxygenation.

Authors:  Yoshiko Kida; Shinichiro Ohshimo; Michihito Kyo; Koji Hosokawa; Vishwa Jeet Amatya; Yukio Takeshima; Nobuaki Shime
Journal:  J Thorac Dis       Date:  2019-11       Impact factor: 2.895

5.  Clinical and radiological features of idiopathic interstitial pneumonias (IIPs): a pictorial review.

Authors:  Stefano Palmucci; Federica Roccasalva; Silvia Puglisi; Sebastiano Emanuele Torrisi; Virginia Vindigni; Letizia Antonella Mauro; Giovanni Carlo Ettorre; Marina Piccoli; Carlo Vancheri
Journal:  Insights Imaging       Date:  2014-05-22

6.  Alveolar epithelial cells undergo epithelial-mesenchymal transition in acute interstitial pneumonia: a case report.

Authors:  Hongbo Li; Jinjin Zhang; Xiaodong Song; Tao Wang; Zhi Li; Dong Hao; Xiaozhi Wang; Qingyin Zheng; Cuiping Mao; Pan Xu; Changjun Lv
Journal:  BMC Pulm Med       Date:  2014-04-23       Impact factor: 3.317

7.  Influence of autoimmune biomarkers on interstitial lung diseases: A tertiary referral center based case-control study.

Authors:  Philippe R Bauer; Sanjay Kalra; Thomas G Osborn; Jennifer St Sauver; Andrew C Hanson; Darrell R Schroeder; Jay H Ryu
Journal:  Respir Med       Date:  2015-01-31       Impact factor: 3.415

8.  Aspergillosis superinfection as a cause of death of crizotinib-induced interstitial lung disease successfully treated with high-dose corticosteroid therapy.

Authors:  Laura Deiana; Salvatore Grisanti; Vittorio Ferrari; Andrea Tironi; Giulia Brugnoli; Laura Ferrari; Giordano Bozzola; Alfredo Berruti
Journal:  Case Rep Oncol       Date:  2015-03-18

Review 9.  Noninvasive respiratory support and patient self-inflicted lung injury in COVID-19: a narrative review.

Authors:  Denise Battaglini; Chiara Robba; Lorenzo Ball; Pedro L Silva; Fernanda F Cruz; Paolo Pelosi; Patricia R M Rocco
Journal:  Br J Anaesth       Date:  2021-06-03       Impact factor: 11.719

10.  Hamman-Rich syndrome.

Authors:  Arshiya Mastan; Nilaani Murugesu; Adil Hasnain; Terry O'Shaughnessy; Vladimir Macavei
Journal:  Respir Med Case Rep       Date:  2017-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.